Skip to main content

Topic

340B

257 published works

  1. Health Care Law Matters

    HHS Issues ‘Last Call’ for Provider Relief Funds – Apply by Nov. 6 for Share of $20 Billion Distribution

    By Susan McNear Fradenburg

    An additional $20 billion in “Provider Relief Funds” is being made available pursuant to the Coronavirus Aid, Relief, and Economic Security (CARES) Act through a “Phase 3” General Distribution. However,…

  2. Healthcare Law Blog

    Maneuvers on the 340B Drug Pricing Program Battlefield: Duplicate Discounts and Contract Pharmacies

    By Sheppard Mullin

    In a December 12, 2017 Advisory Board article, “The 340B drug pricing controversy, explained,” Scott Orwig wrote, “the 340B Drug Pricing Program is one of the most contentious issues in…

  3. Medicaid and the Law

    The 340B Contract Pharmacy Saga

    By Alexander Somodevilla

    We are back again with another 340B post. The 340B program has recently been a regular feature on the blog in the context of ongoing litigation discussed here and here.…

  4. Pharmacy & Healthcare Legal Blog

    Manufacturers exiting 340b program

    By Natalia Mazina

    Since the inception of the 340b program, drug manufacturers have been attempting to curtail it to avoid offering discounts or to prevent double discounts (which occurs when a 340b drug…

  5. Medicaid and the Law

    CMS Prevails in Litigation Challenging Pricing Policy for 340B Drugs

    By Thomas Barker

    We’ve written before about the 340B program, which allows some health service providers that treat low-income patients to purchase outpatient prescription drugs at  deeply discounted prices.  It’s related (at least…

  6. To Be or Not to 340B Blog

    Notice to Covered Entities: Manufacturer Seeking 340B Claims Data

    By Brenda Maloney Shafer, Richard Davis

    While we addressed recent wins for 340B covered entities concerning manufacturer transparency in a previous article, Merck Sharpe & Dohme Corp. ("Merck" or "Manufacturer") now appears to seek its own…

  7. Privacy World

    Court Punts Breach of Privacy Lawsuit in a Sweeping Defense Victory

    By Squire Patton Boggs, Angelo Carosio

    Can you remember the last time you were able to get your prescription medication from the drug store without giving your name, home address and/or date of birth? What about…

  8. Banking Law Update

    Financial Institutions . . . In the News

    By James I. Cohen

    Hundreds of business owners filing federal aid applications with lenders. (Portland Press Herald 4.6.2020) Maine Securities Administrator Judith Shaw cautions to be careful of scammers. (Central Maine 4.6.2020) New Dimensions…

  9. To Be or Not to 340B Blog

    HRSA Unveils New 340B Flexibilities During COVID-19 Crisis

    By Brenda Maloney Shafer, Richard Davis

    As the COVID-19 crisis continues to unfold, the Health Resources & Services Administration Office of Pharmacy Affairs (HRSA OPA) has taken unprecedented steps to provide 340B Program participants with additional…

  10. To Be or Not to 340B Blog

    GAO Report Suggests Increased Oversight of 340B Program

    By Brenda Maloney Shafer, Richard Davis

    On January 10, 2020, the Government Accountability Office (GAO) released a report which "found weaknesses in the Health Resources and Services Administration’s (HRSA) oversight [of the 340B Program] that may result in some…